Author: Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, Lacy M, Lipe B, Little RF, Nikonova A, Omel J, Peswani N, Prica A, Raje N, Seth R, Vesole DH, Walker I, Whitley A, Wildes TM, Wong SW, Martin T
Year: 2019
AGREE II score: Available
Developer organization: American Society of Clinical Oncology
Type of cancer: Not disease site specific
Patient population: Adult
Location: Canada-wide, International, Ontario
This is a clinical practice guideline for patients with multiple myeloma. The guideline provides recommendations for the treatment of both newly diagnosed and relapsed patients. Outcomes of interest include overall survival, progression-free survival, response rate, and quality of life.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 83.3%
Applicability: 56.2%
Stakeholder involvement: 75%
Editorial independence: 79.2%
Rigour: 79.2%
Clarity presentation: 91.7%
